NCT03611699View on ClinicalTrials.gov

Static Lung Hyperinflation and Sympathetic Nerve Activity-Associated Large Artery Stiffness in COPD Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 24, 2019

Primary Completion Date

April 1, 2020

Study Completion Date

April 1, 2020

Conditions
COPD
Interventions
DRUG

Umeclidinium / Vilanterol Dry Powder Inhaler

umeclidinium/vilanterol dry powder inhaler

DRUG

Placebo

Placebo inhaler

Trial Locations (1)

52242

The University of Iowa Hospital and Clinics, Iowa City

All Listed Sponsors
lead

Gary L. Pierce

OTHER

NCT03611699 - Static Lung Hyperinflation and Sympathetic Nerve Activity-Associated Large Artery Stiffness in COPD Patients | Biotech Hunter | Biotech Hunter